⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2025

Figure S2 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors

Satoru Oya Hideki Yoshida Akimasa Tomida Mitsuru Miyachi Shigeki Yagyu Yoshiki Katsumi Ken Kikuchi Kunihiko Tsuchiya Eiichi Konishi Subbaya Subramanian Masato Yamamoto Tomoko Iehara

View at Publisher

Ask AI

Bookmark

Share

Key Points

The oncolytic adenovirus significantly inhibits the growth of rhabdoid tumors.
Tumor responses correlated with sall4 expression levels, highlighting its role in treatment effectiveness.
Assessment using TARGET database provided insights into the molecular characteristics of rhabdoid tumors.
Findings suggest that targeting sall4 could be a promising strategy in developing cancer therapies.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

This study demonstrates oncolytic adenovirus impacts tumor growth in rhabdoid tumors, suggesting potential cancer therapy applications.

Abstract

SALL4 expression in Rhabdoid Tumors in the TARGET database

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oya et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a219bd https://doi.org/10.1158/1535-7163.30255530

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S1 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors2025
2Figure S4 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors2025
3Table S1 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors2025
4Data from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors2025
5Figure S8 from m<sup>6</sup>A-Modified SFTA1P Acts as a Tumor Suppressor in Non–Small Cell Lung Cancer by Regulating TGFBR2 and P-TEFb2025
6Table S1 from m<sup>6</sup>A-Modified SFTA1P Acts as a Tumor Suppressor in Non–Small Cell Lung Cancer by Regulating TGFBR2 and P-TEFb2025
7SALL4: An Intriguing Therapeutic Target in Cancer TreatmentReview · 2022 · 35 citations
8Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential TherapyOriginal Research · 2021 · 27 citations